Advertisements



5 Reasons Big Biotech Could Gain 25%-30%

Leerink analyst Geoff Porges sees 25% or better upside ahead for Big Biotech. Here's why.....»»

Category: blogSource: barronsMay 19th, 2017

Carnival: 3 Reasons For Smooth Sailing

One team of analysts sees three reasons shares of Carnival can continue to rise despite their big gain this year......»»

Category: blogSource: barronsJul 5th, 2017

After Bluebird"s 75% Gain In 2017, Analysts At BTIG Downgrade To Neutral

Shares of bluebird bio Inc (NASDAQ: BLUE) have gained 75 percent since the start of 2017, which prompted analysts at BTIG to downgrade the biotech company at the forefront of fighting against cancer. Latest Ratings for BL.....»»

Category: blogSource: benzingaJun 30th, 2017

Forget Big Tech, Biotech ETFs are Soaring Higher

Biotech stocks are surging of late; we discuss the reasons behind the rebound and highlight the best performing ETFs. Biotech stocks have been surging over the past 2-3 weeks, as the high-flying tech stocks.....»»

Category: topSource: zacksJun 29th, 2017

4 Reasons Coach Can Gain 20%

Shares of Coach are gaining today after Buckingham Research upgraded the stock to Buy......»»

Category: blogSource: barronsJun 26th, 2017

Go, Gilead, Go!

After lagging other biotech stocks, shares of Gilead Sciences are on pace for their biggest two-day gain since 2012......»»

Category: blogSource: barronsJun 22nd, 2017

5 Reasons Why Biotech ETFs are Soaring

Reasons that propelled the biotech space and the related ETFs higher. The biotech sector is going through the roof right now with SPDR S&P Biotech ETF XBI adding over 9.4.....»»

Category: topSource: zacksJun 22nd, 2017

Biotech ETF IBB on pace for best weekly gain in 7 months

A popular fund used to invest in the biotechnology sec.....»»

Category: topSource: marketwatchJun 22nd, 2017

Biotech ETF IBB on pace for best weekly gain 7 months

A popular fund used to invest in the biotechnology sec.....»»

Category: topSource: marketwatchJun 22nd, 2017

5 reasons to buy biotech stocks now

The medical gains are off the charts and won’t be stifled by a slowing economy, says Michael Brush......»»

Category: topSource: moneycentralJun 20th, 2017

Five reasons you have to buy biotech stocks now

The medical gains are off the charts and won’t be stifled by a slowing economy, says Michael Brush......»»

Category: topSource: marketwatchJun 20th, 2017

6 Reasons to Add Apogee (APOG) Stock to Your Portfolio Now

Apogee (APOG) is poised to gain from positive estimate revi.....»»

Category: topSource: zacksJun 19th, 2017

Why Protagonist Therapeutics Shares Are Climbing

Protagonist Therapeutics saw its shares make a solid gain early on Tuesday after the company announced a key worldwide licensing and collaboration agreement with Janssen Biotech......»»

Category: blogSource: 247wallstMay 30th, 2017

6 Reasons to Add Deere & Company (DE) Stock to Your Portfolio

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Deere (DE) stock is poised to gain from positive estimate revisions and upbeat outlook. The post 6 Reasons to Add Deere & Company (DE) Stock to Your Portfolio appeared first on InvestorPlace......»»

Category: topSource: investorplaceMay 30th, 2017

7 Reasons to Add Rockwell Automation to Your Portfolio Now

Rockwell Automation (ROK) is poised to gain from positive estimate revisions and outlook. Shares of Rockwell Automation Inc. ROK, the original.....»»

Category: topSource: zacksMay 18th, 2017

Biotech Forum Daily Digest: Keytruda Continues To Gain Momentum. Revisiting Amicus Therapeutics After Earnings

Biotech Forum Daily Digest: Keytruda Continues To Gain Momentum. Revisiting Amicus Therapeutics After Earnings.....»»

Category: topSource: seekingalphaMay 12th, 2017

Gilead Sciences shares fall after earnings miss

Gilead Sciences Inc. shares declined in the extended session Tuesday after the biotech company's quarterly earnings fell short of Wall Street estimates. Gilead shares fell 3.2% to $66.39 after hours, following a 0.7% gain in the regular session. .....»»

Category: topSource: marketwatchMay 2nd, 2017

Biogen: Stuck in a Rut?

Shares of Biogen (BIIB) are soaring today after the biotech giant released earnings today. Despite the big gain, shares o.....»»

Category: blogSource: barronsApr 25th, 2017

Jeff Reeves"s Strength in Numbers: Why biotech stocks are a healthy bet in a sickly broader market

Jeff Reeves lists 4 reasons to invest in biotech plays right now......»»

Category: topSource: marketwatchApr 20th, 2017

3 Reasons To Buy Proofpoint, According To DA Davidson

Need a reason to buy shares of Proofpoint Inc (NASDAQ: PFPT) despite a 45 percent gain over the past year? Analysts at DA Davidson are offering three. Latest.....»»

Category: blogSource: benzingaApr 19th, 2017

6 Reasons Gilead Sciences Could Be the World"s Most Perfect Stock

This biotech blue chip could be a perfect addition to your portfolio......»»

Category: topSource: foxnewsApr 3rd, 2017